Insider transactions

EDGAR

SCILEX HOLDING COMPANY

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
3 transactions, 20,657,300 shares
Sum of shares × price per share: 12,771,579.7464

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–7 of 7

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-07-03 Filed 2026-07-07SCLX Stock Acquisition JV LLC 10% owner
J

Other acquisition or disposition (describe transaction)

Common stock
Disposed (D)500,000——958,263Direct (D) No
F1, F2
  • F1 On July 3, 2026, the Reporting Person entered into a letter agreement (the Letter Agreement) with Quantum Scan Holdings, Inc. (Q Scan) and the other party named therein, pursuant to which the Reporting Person transferred the shares reported herein to Q Scan in exchange for shares of common stock of Q Scan. The price at which the shares reported herein are being transferred to Q Scan will be based on the closing price of the shares of Scilex common stock on the Nasdaq Capital Market on the last trading day immediately prior to the transfer of such shares pursuant to the Letter Agreement.
  • F2 The number of shares beneficially owned reflects the 1-for-35 reverse stock split effected April 15, 2025.
Open filing 0001193125-26-297858 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-20Ji Henry Director · Officer: Exec Chair, CEO and President
S

Open market or private sale of non-derivative or derivative security

Derivative security: Warrant (right to buy) — underlying Common Stock (650,000) — exercise price 1.20
Disposed (D)650,0000.1538
99,970

Derived: shares × price per share. Exact value 99970.0000.

2,600,000Direct (D) No— Open filing 0001193125-26-162846 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-20Ma Stephen Hoi Director · Officer: CFO, COO and Secretary
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrant (right to buy) — underlying Common Stock (650,000) — exercise price 1.20
Acquired (A)650,0000.1538
99,970

Derived: shares × price per share. Exact value 99970.0000.

650,000Direct (D) No— Open filing 0001193125-26-162857 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-20Ji Henry Director · Officer: Exec Chair, CEO and President
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrant (right to buy) — underlying Common Stock (3,250,000) — exercise price 1.20
Acquired (A)3,250,0000.1538
499,850

Derived: shares × price per share. Exact value 499850.0000.

3,250,000Direct (D) No— Open filing 0001193125-26-162846 Read from the filing’s XML Dispute this row
2025-12-30 Filed 2025-12-30Scilex Holding Co 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,657,3000.5394
5,209,147.62

Derived: shares × price per share. Exact value 5209147.6200.

244,445,260Direct (D) No— Open filing 0001193125-25-337437 Read from the filing’s XML Dispute this row
2025-12-29 Filed 2025-12-30Scilex Holding Co 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,310,9840.6555
4,792,350.012

Derived: shares × price per share. Exact value 4792350.0120.

254,102,560Direct (D) No— Open filing 0001193125-25-337437 Read from the filing’s XML Dispute this row
2025-12-26 Filed 2025-12-30Scilex Holding Co 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,689,0160.7509
2,770,082.1144

Derived: shares × price per share. Exact value 2770082.1144.

261,413,544Direct (D) No— Open filing 0001193125-25-337437 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–8 of 8

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Cruiser Capital Advisors, LLC 49,999 SH4,995 dollarsUnchanged Prior quarter: 49,999Open filing 0000897069-26-001940 Filed 2026-11-16 Dispute this row
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. Partly reported under another manager42,343 SH4,230 dollarsUnchanged Prior quarter: 42,343Open filing 0000919574-26-007537 Filed 2026-11-10 Dispute this row
Virtu Financial LLC Partly reported under another manager26,303 SH3 dollarsLower by 8,494 Prior quarter: 34,797Open filing 0001533964-26-000015 Filed 2026-11-17 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager22,692 SH2,267 dollarsNot in the prior quarter’s filings read Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Clear Street Group Inc. 2,946 SH294 dollarsHigher by 66 Prior quarter: 2,880Open filing 0001881567-26-000006 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager568 SH57 dollarsHigher by 413 Prior quarter: 155Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager418 SH38 dollarsNot in the prior quarter’s filings read Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
TORONTO DOMINION BANK Partly reported under another manager100 SH10 dollarsNot in the prior quarter’s filings read Open filing 0002052595-26-000123 Filed 2026-11-16 Dispute this row
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
SCLX Stock Acquisition JV LLC Common Stock, $0.0001 par value per share11.430,029,37807/03/2026 Filed 2026-07-07SCHEDULE 13D/AAmendment 6Open filing 0001193125-26-297859 Dispute this row
Oramed Pharmaceuticals Inc. Common Stock, par value $0.0001 per share4.9437,51012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 4Open filing 0001012975-26-000138 Dispute this row
Oramed Pharmaceuticals Inc. Common Stock, par value $0.0001 per share9.9833,47309/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 3Open filing 0001012975-25-000769 Dispute this row
Oramed Pharmaceuticals Inc. Common Stock par value $0.0001 per share9.9764,277.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0001213900-25-076929 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,561,196 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020187,489
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to SCILEX HOLDING COMPANY